• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

库欣综合征与白内障的高发病率及发病年龄提前相关:一项全国性回顾性队列研究。

Cushing's syndrome related to higher rates and earlier onset of cataract: A nationwide retrospective cohort study.

作者信息

Sharon Yael, Shochat Tzipora, Rudman Yaron, Kushnir Shiri, Zahavi Alon, Shimon Ilan, Fleseriu Maria, Akirov Amit

机构信息

Ophthalmology Department, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel.

School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2025 May;263(5):1345-1353. doi: 10.1007/s00417-025-06752-6. Epub 2025 Jan 23.

DOI:10.1007/s00417-025-06752-6
PMID:39847049
Abstract

PURPOSE

To investigate the risk of cataract in patients with Cushing's syndrome (CS) and evaluate whether disease onset occurs at an earlier age compared to general population.

METHODS

A nationwide retrospective matched-cohort study including individuals diagnosed with endogenous CS from 2000 to 2023. Patients with CS were matched in a 1:5 ratio with a control group individually matched for age, sex, socioeconomic status, and body mass index. The primary outcome was the incidence of cataract and cataract surgery. The Cox proportional hazards model, accounting for death without cataract as a competing risk, was employed to estimate hazard ratio.

RESULTS

The study cohort included 609 patients with CS, 65% women and 35% men, and 3018 controls. The average age at CS diagnosis was 48.1 ± 17 years. Follow-up duration was 14.6 years (IQR 9.8-20.2). The source of hypercortisolism was Cushing's disease (CD) in 259 (42.6%) and adrenal CS (aCS) in 206 patients (33.8%). After CS diagnosis, cataract was observed in 171 patients (28.1%), and 771 controls (25.5%). Patients with CS had a 34% higher risk of developing cataract compared to their matched controls (HR = 1.34, 95% CI 1.03-1.75, p = 0.03). Cataract developed earlier in patients with CS compared to controls, with a mean age of onset at 64.7 ± 9.7 versus 67.6 ± 8.4 years, respectively (p = 0.01). A total of 49 (8.05%) patients had undergone cataract surgery after a diagnosis of CS compared to 177 (5.86%) in the control group (p = 0.07).

CONCLUSION

Patients with endogenous CS have an increased likelihood of developing cataracts and they experienced onset at a younger age. Guidelines should include annual cataract monitoring for CS patients, beginning 3-5 years earlier than the current general recommendations.

摘要

目的

研究库欣综合征(CS)患者患白内障的风险,并评估与普通人群相比,疾病发病年龄是否更早。

方法

一项全国性回顾性匹配队列研究,纳入2000年至2023年诊断为内源性CS的个体。CS患者与对照组按1:5的比例进行匹配,对照组个体在年龄、性别、社会经济地位和体重指数方面进行单独匹配。主要结局是白内障和白内障手术的发生率。采用Cox比例风险模型,将无白内障死亡作为竞争风险,来估计风险比。

结果

研究队列包括609例CS患者,其中65%为女性,35%为男性,以及3018例对照。CS诊断时的平均年龄为48.1±17岁。随访时间为14.6年(四分位间距9.8 - 20.2)。高皮质醇血症的来源为库欣病(CD)259例(42.6%),肾上腺CS(aCS)206例(33.8%)。CS诊断后,171例患者(28.1%)出现白内障,771例对照(25.5%)出现白内障。与匹配的对照组相比,CS患者患白内障的风险高34%(HR = 1.34,95%CI 1.03 - 1.75,p = 0.03)。与对照组相比,CS患者白内障发病更早,平均发病年龄分别为64.7±9.7岁和67.6±8.4岁(p = 0.01)。CS诊断后,共有49例(8.05%)患者接受了白内障手术,而对照组为177例(5.86%)(p = 0.07)。

结论

内源性CS患者患白内障的可能性增加,且发病年龄更小。指南应包括对CS患者进行每年一次的白内障监测,比目前的一般建议提前3 - 5年开始。

相似文献

1
Cushing's syndrome related to higher rates and earlier onset of cataract: A nationwide retrospective cohort study.库欣综合征与白内障的高发病率及发病年龄提前相关:一项全国性回顾性队列研究。
Graefes Arch Clin Exp Ophthalmol. 2025 May;263(5):1345-1353. doi: 10.1007/s00417-025-06752-6. Epub 2025 Jan 23.
2
Higher risk and earlier onset glaucoma in Cushing's syndrome.库欣综合征患者青光眼风险更高且发病更早。
Acta Ophthalmol. 2025 May;103(3):e176-e182. doi: 10.1111/aos.16787. Epub 2024 Nov 5.
3
Endogenous Cushing's syndrome and cancer risk.内源性库欣综合征与癌症风险。
Eur J Endocrinol. 2024 Aug 5;191(2):223-231. doi: 10.1093/ejendo/lvae098.
4
Impact of remission status in endogenous Cushing's syndrome on cancer incidence.内源性库欣综合征缓解状态对癌症发病率的影响。
Eur J Endocrinol. 2025 Mar 3;192(3):266-276. doi: 10.1093/ejendo/lvaf028.
5
Can we predict the risk of venous thromboembolism in patients with Cushing's syndrome: a nationwide cohort analysis.我们能否预测库欣综合征患者发生静脉血栓栓塞的风险:一项全国性队列分析。
Pituitary. 2024 Dec 27;28(1):10. doi: 10.1007/s11102-024-01482-0.
6
Mortality in Cushing's syndrome: declining over 2 decades but remaining higher than the general population.库欣综合征的死亡率:二十多年来呈下降趋势,但仍高于普通人群。
Eur J Endocrinol. 2025 Mar 27;192(4):445-455. doi: 10.1093/ejendo/lvaf059.
7
Leukocytosis in Cushing's syndrome persists post-surgical remission and could predict a lower remission prognosis in patients with Cushing's disease.库欣综合征患者术后缓解期仍存在白细胞增多,且这可能预示着库欣病患者的缓解预后较差。
J Endocrinol Invest. 2025 May;48(5):1217-1224. doi: 10.1007/s40618-025-02535-2. Epub 2025 Jan 28.
8
Impact of Cushing's syndrome on the gonadotrope axis and testicular functions in men.库欣综合征对男性促性腺激素轴和睾丸功能的影响。
Hum Reprod. 2023 Dec 4;38(12):2350-2361. doi: 10.1093/humrep/dead187.
9
Risk of obstructive sleep apnea among patients with Cushing's syndrome: a nationwide longitudinal study.库欣综合征患者发生阻塞性睡眠呼吸暂停的风险:一项全国性纵向研究。
Sleep Med. 2017 Aug;36:44-47. doi: 10.1016/j.sleep.2017.04.016. Epub 2017 May 27.
10
Impact of etiology, sex, diabetes mellitus and remission status on erythrocytic profile in patients with cushing's syndrome: a large population database study.病因、性别、糖尿病和缓解状态对库欣综合征患者红细胞参数的影响:一项大型人群数据库研究。
Pituitary. 2024 Aug;27(4):389-402. doi: 10.1007/s11102-024-01399-8. Epub 2024 May 20.

本文引用的文献

1
Higher risk and earlier onset glaucoma in Cushing's syndrome.库欣综合征患者青光眼风险更高且发病更早。
Acta Ophthalmol. 2025 May;103(3):e176-e182. doi: 10.1111/aos.16787. Epub 2024 Nov 5.
2
Metabolic disorders during endogenous Cushing's syndrome: prevalence, associated factors, and outcome after remission.内源性库欣综合征期间的代谢紊乱:患病率、相关因素和缓解后的结果。
Endocr Regul. 2023 Aug 10;57(1):138-143. doi: 10.2478/enr-2023-0017. Print 2023 Jan 1.
3
Cushing Syndrome: A Review.库欣综合征:综述。
JAMA. 2023 Jul 11;330(2):170-181. doi: 10.1001/jama.2023.11305.
4
Evaluation of Systemic Medications Associated With Surgically Treated Cataract Among US Adults.美国成年人中与手术治疗白内障相关的全身用药评估。
Am J Ophthalmol. 2023 May;249:126-136. doi: 10.1016/j.ajo.2023.01.005. Epub 2023 Jan 14.
5
Drugs associated with cataract formation represent an unmet need in cataract research.与白内障形成相关的药物是白内障研究中尚未满足的需求。
Front Med (Lausanne). 2022 Aug 15;9:947659. doi: 10.3389/fmed.2022.947659. eCollection 2022.
6
Approach to the Patient: Diagnosis of Cushing Syndrome.患者评估:库欣综合征的诊断。
J Clin Endocrinol Metab. 2022 Nov 23;107(11):3162-3174. doi: 10.1210/clinem/dgac492.
7
Consensus on diagnosis and management of Cushing's disease: a guideline update.库欣病的诊断和治疗共识:指南更新。
Lancet Diabetes Endocrinol. 2021 Dec;9(12):847-875. doi: 10.1016/S2213-8587(21)00235-7. Epub 2021 Oct 20.
8
Global and regional prevalence of age-related cataract: a comprehensive systematic review and meta-analysis.全球和地区与年龄相关的白内障患病率:全面的系统评价和荟萃分析。
Eye (Lond). 2020 Aug;34(8):1357-1370. doi: 10.1038/s41433-020-0806-3. Epub 2020 Feb 13.
9
Cushing's Disease - Quality of Life, Recurrence and Long-term Morbidity.库欣病——生活质量、复发及长期发病率
Eur Endocrinol. 2015 Apr;11(1):34-38. doi: 10.17925/EE.2015.11.01.34. Epub 2015 Apr 11.
10
Complications of Cushing's syndrome: state of the art.库欣综合征的并发症:最新进展。
Lancet Diabetes Endocrinol. 2016 Jul;4(7):611-29. doi: 10.1016/S2213-8587(16)00086-3. Epub 2016 May 10.